Shinkyo Yoon

Shinkyo Yoon

UNVERIFIED PROFILE

Are you Shinkyo Yoon?   Register this Author

Register author
Shinkyo Yoon

Shinkyo Yoon

Publications by authors named "Shinkyo Yoon"

Are you Shinkyo Yoon?   Register this Author

31Publications

604Reads

15Profile Views

Gemcitabine plus carboplatin versus gemcitabine plus oxaliplatin in cisplatin-unfit patients with advanced urothelial carcinoma: a randomised phase II study (COACH, KCSG GU10-16).

Eur J Cancer 2020 Mar 24;127:183-190. Epub 2019 Oct 24.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.08.034DOI Listing
March 2020

A multicenter, prospective phase II trial of gemcitabine plus axitinib in patients with renal cell carcinoma with a predominant sarcomatoid component.

Invest New Drugs 2019 12 24;37(6):1239-1246. Epub 2019 Jun 24.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-019-00817-0DOI Listing
December 2019

CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.

Cell Oncol (Dordr) 2019 Aug 5;42(4):449-458. Epub 2019 Mar 5.

Department of Oncology, Asan Medical Center, College of Medicine, University of Ulsan, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13402-019-00434-2DOI Listing
August 2019

Exceptional pemetrexed sensitivity can predict therapeutic benefit from subsequent chemotherapy in metastatic non-squamous non-small cell lung cancer.

J Cancer Res Clin Oncol 2019 Jul 29;145(7):1897-1905. Epub 2019 May 29.

Department of Oncology, Asan Medical Center, College of Medicine, University of Ulsan, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-019-02941-zDOI Listing
July 2019

Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations.

Onco Targets Ther 2019 26;12:6045-6052. Epub 2019 Jul 26.

Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S213928DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6666367PMC
July 2019

Comparison of T790M Acquisition Between Patients Treated with Afatinib and Gefitinib as First-Line Therapy: Retrospective Propensity Score Matching Analysis.

Transl Oncol 2019 Jun 25;12(6):852-858. Epub 2019 Apr 25.

Department of Oncology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2019.04.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484288PMC
June 2019

The GTP binding activity of transglutaminase 2 promotes bone metastasis of breast cancer cells by downregulating microRNA-205.

Am J Cancer Res 2019 1;9(3):597-607. Epub 2019 Mar 1.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine Seoul 05505, Republic of Korea.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448065PMC
March 2019

The different path of T790M-positive EGFR-mutant lung cancer.

Ann Transl Med 2018 Nov;6(Suppl 1):S47

Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2018.10.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291558PMC
November 2018

Osimertinib, the winner, but cannot yet take it all.

Ann Transl Med 2018 Feb;6(3):61

Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2017.12.27DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879536PMC
February 2018

Relevance of prognostic index with β2-microglobulin for patients with diffuse large B-cell lymphoma in the rituximab era.

Blood Res 2017 Dec 26;52(4):276-284. Epub 2017 Dec 26.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2017.52.4.276DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762738PMC
December 2017

Comments on the trial of cisplatin and etoposide plus thoracic radiotherapy followed by nivolumab or placebo for locally advanced non-small cell lung cancer (RTOG 3505).

J Thorac Dis 2017 Oct;9(10):3525-3528

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2017.09.12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723812PMC
October 2017

Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB-IV gastric cancer.

Gastric Cancer 2017 Jan 11;20(1):182-189. Epub 2015 Dec 11.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-015-0580-2DOI Listing
January 2017

Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer.

J Cancer Res Clin Oncol 2016 Aug 23;142(8):1775-80. Epub 2016 Jun 23.

Department of Oncology/Hematology, Cancer Research Institute, Kyungpook National University, 807 Hoguk-ro, Buk-gu, Daegu, 702-210, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-016-2196-2DOI Listing
August 2016

Clinical Implication of Serine Metabolism-Associated Enzymes in Colon Cancer.

Oncology 2015 7;89(6):351-9. Epub 2015 Oct 7.

Department of Oncology/Hematology, Kyungpook National University School of Medicine, Daegu, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000439571DOI Listing
March 2016

The efficacy of prophylactic azithromycin on bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Int J Hematol 2015 Sep 30;102(3):357-63. Epub 2015 Jun 30.

Division of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-015-1830-0DOI Listing
September 2015

Multi-center Randomized Phase II Study of Weekly Docetaxel Versus Weekly Docetaxel-plus-Oxaliplatin as a Second-line Chemotherapy for Patients with Advanced Gastric Cancer.

Anticancer Res 2015 Jun;35(6):3531-6

Department of Oncology/Hematology, Kyungpook National University Medical Center, Kyungpook National University School of Medicine, Daegu, Republic of Korea

View Article

Download full-text PDF

Source
June 2015

A Phase I study of cabazitaxel in patients with advanced gastric cancer who have failed prior chemotherapy (GASTANA).

Cancer Chemother Pharmacol 2015 Feb 9;75(2):309-18. Epub 2014 Dec 9.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2638-yDOI Listing
February 2015

A Phase I study of cabazitaxel in patients with advanced gastric cancer who have failed prior chemotherapy (GASTANA).

Cancer Chemother Pharmacol 2015 Feb 9;75(2):309-18. Epub 2014 Dec 9.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2638-yDOI Listing
February 2015

Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.

Ann Hematol 2014 Jun 19;93(6):995-1000. Epub 2014 Jan 19.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00277-014-2015
Web Search
http://link.springer.com/10.1007/s00277-014-2015-2
Publisher Site
http://dx.doi.org/10.1007/s00277-014-2015-2DOI Listing
June 2014

Imatinib plasma monitoring-guided dose modification for managing imatinib-related toxicities in gastrointestinal stromal tumor patients.

J Korean Med Sci 2013 Aug 31;28(8):1248-52. Epub 2013 Jul 31.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3346/jkms.2013.28.8.1248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744717PMC
August 2013

A unique pattern of extranodal involvement in Korean adults with sporadic Burkitt lymphoma: a single center experience.

Ann Hematol 2012 Dec 5;91(12):1917-22. Epub 2012 Aug 5.

Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-012-1531-1DOI Listing
December 2012

Pneumatosis intestinalis after cetuximab-containing chemotherapy for colorectal cancer.

Jpn J Clin Oncol 2011 Oct 10;41(10):1225-8. Epub 2011 Aug 10.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 86 Asanbyeongwon-gil, Poongnap-dong, Songpa-gu, Seoul 138-736, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyr114DOI Listing
October 2011